154 related articles for article (PubMed ID: 1703215)
1. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
Hastings GZ; Speller SA; Francis MJ
J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
[TBL] [Abstract][Full Text] [Related]
2. A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
Skern T; Neubauer C; Frasel L; Gründler P; Sommergruber W; Zorn M; Kuechler E; Blaas D
J Gen Virol; 1987 Feb; 68 ( Pt 2)():315-23. PubMed ID: 2434607
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
Barnett PV; Rowlands DJ; Parry NR
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence.
Barnett PV; Rowlands DJ; Campbell RO; Parry NR
J Gen Virol; 1995 May; 76 ( Pt 5)():1255-61. PubMed ID: 7730811
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
6. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.
Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF
Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339
[TBL] [Abstract][Full Text] [Related]
7. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2.
Francis MJ; Hastings GZ; Sangar DV; Clark RP; Syred A; Clarke BE; Rowlands DJ; Brown F
J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846
[TBL] [Abstract][Full Text] [Related]
8. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
Hwang GY; Li JK
Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
[TBL] [Abstract][Full Text] [Related]
9. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
Tormo J; Blaas D; Parry NR; Rowlands D; Stuart D; Fita I
EMBO J; 1994 May; 13(10):2247-56. PubMed ID: 8194515
[TBL] [Abstract][Full Text] [Related]
11. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide.
Langeveld JP; Casal JI; Cortés E; van de Wetering G; Boshuizen RS; Schaaper WM; Dalsgaard K; Meloen RH
Vaccine; 1994 Nov; 12(15):1473-80. PubMed ID: 7887026
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
[TBL] [Abstract][Full Text] [Related]
13. The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses.
Gould AR; Eaton BT
Virus Res; 1990 Nov; 17(3):161-72. PubMed ID: 1706548
[TBL] [Abstract][Full Text] [Related]
14. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
Martínez-Torrecuadrada JL; Casal JI
Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
[TBL] [Abstract][Full Text] [Related]
15. Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides.
Martínez-Torrecuadrada JL; Langeveld JPM; Meloen RH; Casal JI
J Gen Virol; 2001 Oct; 82(Pt 10):2415-2424. PubMed ID: 11562535
[TBL] [Abstract][Full Text] [Related]
16. Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.
Niespodziana K; Cabauatan CR; Pazderova P; Vacal PC; Wortmann J; Keller W; Errhalt P; Valenta R
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563505
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping of canine parvovirus B cell epitopes.
López de Turiso JA; Cortés E; Ranz A; García J; Sanz A; Vela C; Casal JI
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2445-56. PubMed ID: 1919526
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
19. The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2.
Speller SA; Sangar DV; Clarke BE; Rowlands DJ
J Gen Virol; 1993 Feb; 74 ( Pt 2)():193-200. PubMed ID: 8381460
[TBL] [Abstract][Full Text] [Related]
20. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J
Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
